This HTML5 document contains 125 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dbpedia-dehttp://de.dbpedia.org/resource/
dctermshttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n9https://global.dbpedia.org/id/
schemahttp://schema.org/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n18http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
n12http://commons.wikimedia.org/wiki/Special:FilePath/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
goldhttp://purl.org/linguistics/gold/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Editas_Medicine
rdf:type
dbo:Organisation dbo:Company owl:Thing schema:Organization wikidata:Q4830453 wikidata:Q43229 dbo:Agent n18:SocialPerson n18:Agent wikidata:Q24229398
rdfs:label
Editas Medicine Editas Medicine
rdfs:comment
Editas Medicine, Inc., (formerly Gengine, Inc.), is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Editas Medicine, ehemals Gengine, Inc., ist ein Biotechnologieunternehmen, das an Therapien auf der Grundlage der CRISPR/Cas-Methode forscht. Editas hat seinen Sitz in Cambridge, Massachusetts, und verfügt über Forschungseinrichtungen in Boulder, Colorado.
foaf:name
Editas Medicine
dbp:name
Editas Medicine
foaf:depiction
n12:Editas_Medicine_logo.png
dcterms:subject
dbc:Pharmaceutical_companies_of_the_United_States dbc:Health_care_companies_based_in_Massachusetts dbc:Companies_listed_on_the_Nasdaq dbc:Pharmaceutical_companies_established_in_2013 dbc:Gene_therapy dbc:Biotechnology_companies_of_the_United_States dbc:Companies_based_in_Cambridge,_Massachusetts
dbo:wikiPageID
49392319
dbo:wikiPageRevisionID
1112516343
dbo:wikiPageWikiLink
dbr:Jennifer_Doudna dbr:FDA dbr:Third_Rock_Ventures dbr:Allergan dbr:Series_B dbr:Sickle_cell_disease dbr:Nucleases dbr:Cambridge,_Massachusetts dbr:Harvard_University dbr:Phases_of_clinical_research dbr:Broad_Institute dbr:Leber_congenital_amaurosis dbr:Boulder,_Colorado dbr:George_M._Church dbr:George_Church_(geneticist) dbc:Pharmaceutical_companies_established_in_2013 dbc:Companies_listed_on_the_Nasdaq dbr:Cas9 dbr:Chimeric_antigen_receptor dbr:David_R._Liu dbr:Bill_Gates dbc:Gene_therapy dbr:In_vivo dbr:Polaris_Partners dbr:Genome_engineering dbr:Biotechnology dbr:AbbVie dbr:Celgene dbr:J._Keith_Joung dbr:Flagship_Ventures dbr:Pharmaceutical dbr:Cas12a dbr:T_cell_receptor dbr:Intravitreal_injection dbr:CRISPR_gene_editing dbr:Bristol_Myers_Squibb dbr:Sarepta_Therapeutics dbr:Russell_2000_Index dbr:Beta_thalassemia dbr:Initial_public_offering dbc:Biotechnology_companies_of_the_United_States dbc:Companies_based_in_Cambridge,_Massachusetts dbr:Feng_Zhang dbc:Pharmaceutical_companies_of_the_United_States dbr:University_of_California,_Berkeley dbc:Health_care_companies_based_in_Massachusetts dbr:Juno_Therapeutics
owl:sameAs
n9:2Bayd yago-res:Editas_Medicine dbpedia-de:Editas_Medicine wikidata:Q23131313
dbp:wikiPageUsesTemplate
dbt:Infobox_company dbt:Short_description dbt:Start_date_and_age dbt:URL dbt:Reflist
dbo:thumbnail
n12:Editas_Medicine_logo.png?width=300
dbp:assets
5.08885E8
dbp:equity
2.62437E8
dbp:equityYear
2019
dbp:founded
in Cambridge, Massachusetts
dbp:founders
dbr:Jennifer_Doudna dbr:George_Church_(geneticist) dbr:Feng_Zhang dbr:David_R._Liu dbr:J._Keith_Joung
dbp:hqLocationCity
Cambridge, Massachusetts
dbp:hqLocationCountry
United States
dbp:industry
dbr:Biotechnology dbr:Pharmaceutical dbr:Genome_engineering
dbp:keyPeople
Gilmore O'Neill
dbp:logo
Editas Medicine logo.png
dbp:numEmployees
208
dbp:numEmployeesYear
2020
dbp:numLocations
2
dbp:tradedAs
dbr:Russell_2000_Index NASDAQ:EDIT
dbp:type
Public company
dbo:abstract
Editas Medicine, Inc., (formerly Gengine, Inc.), is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Editas Medicine, ehemals Gengine, Inc., ist ein Biotechnologieunternehmen, das an Therapien auf der Grundlage der CRISPR/Cas-Methode forscht. Editas hat seinen Sitz in Cambridge, Massachusetts, und verfügt über Forschungseinrichtungen in Boulder, Colorado.
dbp:assetsYear
2019
gold:hypernym
dbr:Company
prov:wasDerivedFrom
wikipedia-en:Editas_Medicine?oldid=1112516343&ns=0
dbo:wikiPageLength
15311
dbo:assets
5.08885E8
dbo:equity
2.62437E8
dbo:numberOfEmployees
208
dbo:numberOfLocations
2
dbo:foundedBy
dbr:Jennifer_Doudna dbr:George_Church_(geneticist) dbr:Feng_Zhang dbr:David_R._Liu dbr:J._Keith_Joung
dbo:industry
dbr:Pharmaceutical dbr:Genome_engineering dbr:Biotechnology
foaf:isPrimaryTopicOf
wikipedia-en:Editas_Medicine